68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
7. Joint Meeting mit der Britischen Gesellschaft für Neurochirurgie (SBNS)
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
14. - 17. Mai 2017, Magdeburg
Vorträge Montag, 15.05.2017
MO.14 Tumor 2 – gemischt A
Meeting Abstract
(MO.14.01)
[Volltext]
Integrative analysis of surgical, neurological and oncological outcomes of corpus callosum glioblastoma multiforme
Franco Jimenez P, Heiland DH, Reinacher P, Masalha W, Mercas B, Schnell O[Volltext]
Meeting Abstract
(MO.14.02)
[Volltext]
AXL tyrosine kinase receptor is widely activated in glioblastoma tissue and is associated with a significant shorter overall survival
Onken JS, Josefine R, Claudia H, Peter V[Volltext]
Meeting Abstract
(MO.14.03)
[Volltext]
Charlston Comorbidity Index (CCI) as an additional prognostic factor for glioblastoma patients
Barz M, Delbridge C, Gerhardt J, Bette S, Meyer B, Gempt J[Volltext]
Meeting Abstract
(MO.14.04)
[Volltext]
Clinical characteristics and molecular assignment of cerebellar glioblastoma
Hong B, Rouzbeh B, Nakamura M, Hartmann C, Krauss JK[Volltext]
Meeting Abstract
(MO.14.05)
[Volltext]
Comparison of the effect of different treatment strategies within discrepant healthcare systems on survival of glioblastoma patients
Stavrinou P, Katsigiannis S, Hamisch CA, Stranjalis G, Krischek B, Goldbrunner R[Volltext]
Meeting Abstract
(MO.14.06)
[Volltext]
High therapy compliance in patients treated with optune does not depend an demographic data, stage of disease ot treatment duration
Misch M, Onken JS, Vajkoczy P[Volltext]
